Is Corvus Pharmaceuticals, Inc. (CRVS) a Buy, Sell, or Hold?
NASDAQ : CRVS
Corvus Pharmaceuticals, Inc. — Institutional Ownership
$12.92 USD
-$0.15 (-1.15%)
- Volume
- 822.34K
- Average Volume
- 1.48M
- Market Capitalization
- $1.09B
- P/E Ratio
- -23.49
- Dividend Yield
- 0.00%
- Price Target
- $35.00
- Year High
- $26.95
- Year Low
- $3.96
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $19.81
Institutional Ownership Summary
Institutional Ownership %
0.41%
Investors Holding
16
change: -157 | last: 173
Increased Positions
8
change: -118 | last: 126
Reduced Positions
4
change: -24 | last: 28
New Positions
3
change: -64 | last: 67
Sold Positions
152
change: 125 | last: 27
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -33.2441 | last: 0.3324
Total Invested
5.27M
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-05-15 | Point72 Asset Management, L.P. | - | 0.00% |
| 2026-05-15 | Sirenia Capital Management LP | 6.83M | 7.50% |
| 2026-04-27 | BlackRock, Inc. | 5.39M | 6.40% |
| 2026-03-26 | The Vanguard Group | - | 0.00% |
| 2026-02-13 | Richard A. Miller | 6.09M | 7.80% |
| 2026-02-05 | Adams Street 2011 Direct Fund LP | 694.85K | 0.80% |
| 2026-02-05 | Adams Street 2012 Direct Fund LP | 715.36K | 0.90% |
| 2026-02-05 | Adams Street 2013 Direct Fund LP | 541.13K | 0.60% |
| 2026-02-05 | Adams Street 2014 Direct Fund LP | 736.03K | 0.90% |
| 2026-02-05 | Adams Street 2017 Direct Venture/Growth Fund LP | 87668.0 | 0.10% |
| 2026-02-05 | Adams Street 2018 Direct Venture/Growth Fund LP | 126.81K | 0.20% |
| 2026-02-05 | Adams Street Venture/Growth Fund VI LP | 236.13K | 0.30% |
| 2026-02-05 | Adams Street Partners, LLC | 3.28M | 3.90% |
| 2026-02-05 | Adams Street 2016 Direct Venture/Growth Fund LP | 67769.0 | 0.10% |
| 2026-02-05 | Adams Street 2015 Direct Venture/Growth Fund LP | 69864.0 | 0.10% |
| 2026-01-30 | The Vanguard Group | 3.87M | 5.18% |
| 2026-01-27 | ORBIMED ADVISORS LLC | 8.61M | 10.30% |
| 2026-01-27 | ORBIMED CAPITAL GP V LLC | 8.61M | 10.30% |
| 2025-10-17 | BlackRock, Inc. | 4.02M | 5.40% |
| 2025-08-14 | SAMLYN CAPITAL, LLC | - | 0.00% |
| 2025-05-15 | SAMLYN CAPITAL, LLC | 4.07M | 6.00% |
| 2025-05-14 | ORBIMED ADVISORS LLC | 9.79M | 12.20% |
| 2025-05-14 | ORBIMED CAPITAL GP V LLC | 9.79M | 12.20% |
| 2025-05-01 | ORBIMED CAPITAL GP V LLC | 9.79M | 13.80% |
| 2025-05-01 | ORBIMED ADVISORS LLC | 9.79M | 13.80% |
| 2025-02-14 | Samlyn Capital, LLC | 6.67M | 9.80% |
| 2025-02-13 | Richard A. Miller | 5.22M | 7.70% |
| 2024-05-09 | Point72 Asset Management, L.P. | 17.05M | 9.90% |
| 2024-05-09 | Steven A. Cohen | 17.05M | 9.90% |
| 2024-05-09 | Point72 Capital Advisors, Inc. | 17.05M | 9.90% |
| 2024-02-14 | Samlyn, LP | 2.5M | 5.10% |
| 2024-02-14 | Robert Pohly | 2.5M | 5.10% |
| 2024-02-14 | Samlyn Capital, LLC | 2.5M | 5.10% |
| 2023-02-13 | CHI Advisors LLC | 2.38M | 5.12% |
| 2022-02-14 | VHCP Management III, LLC | 250K | 0.50% |
| 2022-02-14 | Venrock Healthcare Capital Partners II, L.P. | 250K | 0.50% |
| 2022-02-14 | VHCP Co-Investment Holdings II, LLC | 250K | 0.50% |
| 2022-02-14 | Venrock Healthcare Capital Partners III, L.P. | 250K | 0.50% |
| 2022-02-14 | Shah, Nimish | 250K | 0.50% |
| 2022-02-14 | VHCP Co-Investment Holdings III, LLC | 250K | 0.50% |
| 2022-02-14 | Venrock Healthcare Capital Partners EG, L.P. | 250K | 0.50% |
| 2022-02-14 | VHCP Management II, LLC | 250K | 0.50% |
| 2022-02-14 | VHCP Management EG, LLC | 250K | 0.50% |
| 2022-02-14 | Koh, Bong | 250K | 0.50% |
| 2022-02-14 | Richard A. Miller | 2.61M | 5.45% |
| 2022-02-14 | BVF GP HOLDINGS LLC | 1.26M | 2.70% |
| 2022-02-14 | Biotechnology Value Trading Fund OS LP | 82043.0 | 1.00% |
| 2022-02-14 | BVF II GP LLC | 533.35K | 1.20% |
| 2022-02-14 | Biotechnology Value Fund II, L.P. | 533.35K | 1.20% |
| 2022-02-14 | Sandra J. Horning | 1.29M | 2.77% |
| 2022-02-14 | BVF I GP LLC | 730.48K | 1.60% |
| 2022-02-14 | of the Miller-Horning Family Trust u/a/d January 25, 1985 | 1.29M | 2.77% |
| 2022-02-14 | BVF Partners OS Ltd. | 82043.0 | 1.00% |
| 2022-02-14 | Biotechnology Value Fund, L.P. | 730.48K | 1.60% |
| 2022-02-14 | Mark N. Lampert | 1.37M | 3.00% |
| 2022-02-14 | BVF Inc. | 1.37M | 3.00% |
| 2022-02-14 | BVF Partners L.P. | 1.37M | 3.00% |
| 2022-01-18 | Millennium International Management LP | 684.45K | 1.50% |
| 2022-01-18 | Millennium Management LLC | 2.92M | 6.30% |
| 2022-01-18 | Millennium Group Management LLC | 2.92M | 6.30% |
| 2022-01-18 | Israel A. Englander | 2.92M | 6.30% |
| 2022-01-18 | Integrated Core Strategies (US) LLC | 2.24M | 4.80% |
| 2022-01-18 | ICS Opportunities, Ltd. | 89.0 | 0.00% |
| 2022-01-18 | Integrated Assets II LLC | 684.36K | 1.50% |
| 2021-12-06 | Millennium International Management LP | 422.13K | 0.90% |
| 2021-12-06 | Integrated Core Strategies (US) LLC | 2.09M | 4.50% |
| 2021-12-06 | ICS Opportunities, Ltd. | 89.0 | 0.00% |
| 2021-12-06 | Integrated Assets II LLC | 422.04K | 0.90% |
| 2021-12-06 | Millennium Management LLC | 2.52M | 5.40% |
| 2021-12-06 | Millennium Group Management LLC | 2.52M | 5.40% |
| 2021-12-06 | Israel A. Englander | 2.52M | 5.40% |
| 2021-10-22 | Millennium International Management LP | 395.85K | 0.90% |
| 2021-10-22 | ICS Opportunities, Ltd. | 89.0 | 0.00% |
| 2021-10-22 | Millennium Group Management LLC | 2.03M | 4.80% |
| 2021-10-22 | Millennium Management LLC | 2.03M | 4.80% |
| 2021-10-22 | Integrated Core Strategies (US) LLC | 1.63M | 3.80% |
| 2021-10-22 | Israel A. Englander | 2.03M | 4.80% |
| 2021-10-22 | Integrated Assets II LLC | 393.54K | 0.90% |
| 2021-10-22 | Integrated Assets, Ltd. | 2224.0 | 0.00% |
| 2021-10-05 | EcoR1 Capital Fund Qualified, L.P. | 42913.0 | 11.00% |
| 2021-10-05 | EcoR1 Capital, LLC | 81077.0 | 11.00% |
| 2021-10-05 | Oleg Nodelman | 81077.0 | 11.00% |
| 2021-09-30 | Shah, Nimish | 3.43M | 8.10% |
| 2021-09-30 | Venrock Healthcare Capital Partners II, L.P. | 3.43M | 8.10% |
| 2021-09-30 | VHCP Management EG, LLC | 3.43M | 8.10% |
| 2021-09-30 | VHCP Management II, LLC | 3.43M | 8.10% |
| 2021-09-30 | Koh, Bong | 3.43M | 8.10% |
| 2021-09-30 | VHCP Management III, LLC | 3.43M | 8.10% |
| 2021-09-30 | VHCP Co-Investment Holdings II, LLC | 3.43M | 8.10% |
| 2021-09-30 | Venrock Healthcare Capital Partners III, L.P. | 3.43M | 8.10% |
| 2021-09-30 | VHCP Co-Investment Holdings III, LLC | 3.43M | 8.10% |
| 2021-09-30 | Venrock Healthcare Capital Partners EG, L.P. | 3.43M | 8.10% |
| 2021-09-23 | EcoR1 Capital, LLC | 5.08M | 11.00% |
| 2021-09-23 | Oleg Nodelman | 5.08M | 11.00% |
| 2021-09-23 | EcoR1 Capital Fund Qualified, L.P. | 4.45M | 11.00% |
| 2021-09-22 | OrbiMed Capital GP V LLC | 6.94M | 16.40% |
| 2021-09-22 | TANG CAPITAL PARTNERS, LP | 3.74M | 8.80% |
| 2021-09-22 | OrbiMed Advisors LLC | 6.94M | 16.40% |
| 2021-08-04 | OrbiMed Capital GP V LLC | 8.05M | 19.00% |
| 2021-08-04 | OrbiMed Advisors LLC | 8.05M | 19.00% |
| 2021-05-11 | EcoR1 Capital Fund Qualified, L.P. | 3.12M | 11.00% |
| 2021-05-11 | EcoR1 Capital, LLC | 3.58M | 11.00% |
| 2021-05-11 | Oleg Nodelman | 3.58M | 11.00% |
| 2021-02-17 | OrbiMed Advisors LLC | 8.05M | 21.98% |
| 2021-02-17 | OrbiMed Capital GP V LLC | 8.05M | 21.98% |
| 2021-02-16 | Richard A. Miller | 2.18M | 7.50% |
| 2021-02-16 | of the Miller-Horning Family Trust u/a/d January 25, 1985 | 1.18M | 4.20% |
| 2021-02-16 | Sandra J. Horning | 1.18M | 4.20% |
| 2020-07-09 | Novo Holdings A/S | 1.39M | 4.97% |
| 2020-04-17 | OrbiMed Capital GP V LLC | 6.77M | 24.20% |
| 2020-04-17 | OrbiMed Advisors LLC | 6.77M | 24.20% |
| 2020-02-18 | BVF I GP LLC | 1.56M | 5.40% |
| 2020-02-18 | BVF II GP LLC | 1.16M | 4.10% |
| 2020-02-18 | Biotechnology Value Fund II, L.P. | 1.16M | 4.10% |
| 2020-02-18 | Biotechnology Value Trading Fund OS LP | 107.4K | 1.00% |
| 2020-02-18 | Mark N. Lampert | 2.92M | 9.90% |
| 2020-02-18 | BVF Inc. | 2.92M | 9.90% |
| 2020-02-18 | BVF Partners L.P. | 2.92M | 9.90% |
| 2020-02-18 | Biotechnology Value Fund, L.P. | 1.56M | 5.40% |
| 2020-02-18 | BVF GP HOLDINGS LLC | 2.72M | 9.30% |
| 2020-02-18 | BVF Partners OS Ltd. | 107.4K | 1.00% |
| 2020-02-14 | BVF I GP LLC | 1.56M | 5.20% |
| 2020-02-14 | BVF GP HOLDINGS LLC | 2.77M | 9.00% |
| 2020-02-14 | BVF Partners L.P. | 3.08M | 9.90% |
| 2020-02-14 | BVF Inc. | 3.08M | 9.90% |
| 2020-02-14 | Mark N. Lampert | 3.08M | 9.90% |
| 2020-02-14 | Biotechnology Value Fund II, L.P. | 1.21M | 4.00% |
| 2020-02-14 | BVF II GP LLC | 1.21M | 4.00% |
| 2020-02-14 | Biotechnology Value Trading Fund OS LP | 210.82K | 1.00% |
| 2020-02-14 | BVF Partners OS Ltd. | 210.82K | 1.00% |
| 2020-02-14 | Biotechnology Value Fund, L.P. | 1.56M | 5.20% |
| 2020-02-14 | 52-0556948 | 647.17K | 2.20% |
| 2020-02-12 | Horning | 1.18M | 4.01% |
| 2020-02-12 | Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 | 1.18M | 4.01% |
| 2020-02-12 | Miller | 1.96M | 6.49% |
| 2019-02-14 | 52-0556948 | 1.99M | 6.70% |
| 2019-02-12 | 13G | 1.76M | 5.89% |
| 2019-02-12 | 13G | 1.13M | 3.85% |
| 2019-02-12 | 13G | 1.13M | 3.85% |
| 2018-03-21 | Adams Street 2017 Direct Venture/Growth Fund LP | 87668.0 | 1.00% |
| 2018-03-21 | Adams Street 2016 Direct Venture/Growth Fund LP | 67769.0 | 1.00% |
| 2018-03-21 | Adams Street 2018 Direct Venture/Growth Fund LP | 126.81K | 1.00% |
| 2018-03-21 | Adams Street 2013 Direct Fund LP | 541.13K | 2.60% |
| 2018-03-21 | Adams Street 2012 Direct Fund LP | 715.36K | 3.40% |
| 2018-03-21 | Adams Street 2014 Direct Fund LP | 736.03K | 3.50% |
| 2018-03-21 | Adams Street 2011 Direct Fund LP | 694.85K | 3.30% |
| 2018-03-21 | Adams Street Venture/Growth Fund VI LP | 236.13K | 1.10% |
| 2018-03-21 | Adams Street 2015 Direct Venture/Growth Fund LP | 69864.0 | 1.00% |
| 2018-03-21 | Adams Street Partners, LLC | 3.28M | 15.50% |
| 2018-03-19 | Biotechnology Value Fund, L.P. | 918.29K | 3.20% |
| 2018-03-19 | BVF Partners OS Ltd. | 157.44K | 1.00% |
| 2018-03-19 | Biotechnology Value Fund II, L.P. | 611.59K | 2.10% |
| 2018-03-19 | Mark N. Lampert | 1.95M | 6.70% |
| 2018-03-19 | BVF Inc. | 1.95M | 6.70% |
| 2018-03-19 | BVF Partners L.P. | 1.95M | 6.70% |
| 2018-03-19 | Biotechnology Value Trading Fund OS LP | 157.44K | 1.00% |
| 2018-02-12 | Adams Street 2013 Direct Fund LP | 541.13K | 2.60% |
| 2018-02-12 | Adams Street 2014 Direct Fund LP | 736.03K | 3.50% |
| 2018-02-12 | Adams Street Partners, LLC | 2.69M | 12.80% |
| 2018-02-12 | Adams Street 2012 Direct Fund LP | 715.36K | 3.40% |
| 2018-02-12 | Adams Street 2011 Direct Fund LP | 694.85K | 3.30% |
| 2018-01-26 | OrbiMed Capital GP V LLC | 5.38M | 25.57% |
| 2018-01-26 | OrbiMed Advisors LLC | 5.38M | 25.57% |
| 2017-02-13 | Adams Street 2012 Direct Fund LP | 715.36K | 3.00% |
| 2017-02-13 | Adams Street Partners, LLC | 2.69M | 13.00% |
| 2017-02-13 | Adams Street 2014 Direct Fund LP | 736.03K | 4.00% |
| 2017-02-13 | Adams Street 2013 Direct Fund LP | 541.13K | 3.00% |
| 2017-02-13 | Adams Street 2011 Direct Fund LP | 694.85K | 3.00% |
| 2017-02-10 | Richard A. Miller | 1.1M | 5.22% |
| 2017-02-10 | Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 | 977.29K | 4.67% |
| 2017-02-10 | Sandra J. Horning | 977.29K | 4.67% |
| 2016-04-08 | Richard A. Miller | 1.07M | 5.23% |
| 2016-04-08 | Sandra J. Horning | 1.05M | 5.13% |
| 2016-04-08 | Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January | 1.05M | 5.13% |
| 2016-04-01 | OrbiMed Capital GP V LLC | 5.26M | 25.77% |
| 2016-04-01 | OrbiMed Advisors LLC | 5.26M | 25.77% |
| 2016-04-01 | Samuel D. Isaly | 5.26M | 25.77% |
CRVS Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $7.70 | 78.96M | $608.03M | $4.58M | $937K | $604.39M |
| 2024-12-31 | $5.35 | 60.99M | $326.27M | $8.74M | $1.12M | $318.65M |
| 2023-12-31 | $1.76 | 48.03M | $84.52M | $12.62M | $1.37M | $73.28M |
| 2022-12-31 | $0.85 | 46.55M | $39.57M | $13.16M | $2.6M | $29.01M |
| 2021-12-31 | $2.41 | 41.85M | $100.87M | $63.46M | $3.65M | $41.06M |
| 2020-12-31 | $3.56 | 29.48M | $104.95M | $16.46M | $2.31M | $90.8M |
| 2019-12-31 | $5.44 | 29.35M | $159.66M | $5.15M | $3.19M | $157.7M |
| 2018-12-31 | $3.67 | 27.51M | $100.96M | $114.6M | -$ | -$13.64M |
| 2017-12-31 | $10.36 | 20.49M | $212.27M | $90.06M | -$ | $122.21M |
| 2016-12-31 | $14.30 | 15.42M | $220.53M | $134.9M | -$ | $85.64M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14.63 | 90M | $1.32B | $40.1M | $834K | $1.28B |
| 2025-12-31 | $7.70 | 78.96M | $608.03M | $4.58M | $937K | $604.39M |
| 2025-09-30 | $7.37 | 82.84M | $610.5M | $2.87M | $1.01M | $608.65M |
| 2025-06-30 | $4.00 | 77.77M | $311.1M | $14.69M | $1.08M | $297.49M |
| 2025-03-31 | $3.18 | 72.13M | $229.36M | $5M | $1.15M | $225.52M |
| 2024-12-31 | $5.35 | 68.35M | $365.66M | $8.74M | $1.12M | $358.04M |
| 2024-09-30 | $5.28 | 66.7M | $352.18M | $4.68M | $354K | $347.86M |
| 2024-06-30 | $1.85 | 59.71M | $110.46M | $14.84M | $700K | $96.32M |
| 2024-03-31 | $1.86 | 49.04M | $91.21M | $7.46M | $1.04M | $84.8M |
| 2023-12-31 | $1.76 | 49.04M | $86.31M | $12.62M | $1.37M | $75.06M |
| 2023-09-30 | $1.46 | 48.97M | $71.5M | $20.1M | $1.69M | $53.08M |
| 2023-06-30 | $2.29 | 47.5M | $108.77M | $7.66M | $2M | $103.11M |